# Study of Lyme Neuroborreliosis

> **NCT01635530** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 210 (actual)

## Conditions studied

- Lyme Neuroborreliosis

## Interventions

- **DRUG:** Doxycycline
- **DRUG:** Ceftriaxone

## Key facts

- **NCT ID:** NCT01635530
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2019-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01635530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01635530, "Study of Lyme Neuroborreliosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01635530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*